#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia Follicle centre lymphoma follicular grade I, II – III Congenital disorder of glycosylation Transferrin decreased Infantile spasms Lymphatic malformation Metastases to peritoneum Hypersomnia Retinitis pigmentosa Fallopian tube cancer Myelodysplastic syndrome Malignant melanoma Non-Hodgkin's lymphoma unspecified histology indolent HER2 mutant non-small cell lung cancer Cervix carcinoma recurrent More trials…

    Learn about Rare Diseases

    Niemann-Pick disease Mucopolysaccharidosis II – Treatment Ocular melanoma Ornithine transcarbamoylase deficiency Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Mucous membrane pemphigoid – Treatment Cerebral arteriovenous malformation haemorrhagic – Basic Information Burkitt’s lymphoma – Basic Information Mucopolysaccharidosis III – Treatment Malignant fibrous histiocytoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Arachis Hypogaea (762) Elacestrant Dihydrochloride VG801-2 FOSFOMYCIN CALCIUM Celecoxib FRUQUINTINIB Inebilizumab [18F]Alf-Nota-Octreotide Poa Pratensis Pollen Extract D-Biotin Bi 1839100 Eo2317 Doxecitine Bi 1819479 LY3372993 Triptorelin Acetate Timolol Ltx-315 Pegfilgrastim Bi 1291583 More therapies…

    Learn about Your Condition

    Vulvovaginal pruritus Kidney transplant rejection Hypoalbuminaemia Testicular leiomyosarcoma HER2 protein overexpression Breast cancer recurrent Rhabdomyosarcoma recurrent Mantle cell lymphoma stage IV Haemorrhage Follicular lymphoma stage II Penile squamous cell carcinoma Hyperhidrosis Oesophagogastroscopy Thalassaemia alpha Ectopic pregnancy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of testosterone supplementation to improve quality of life in male patients receiving palliative care who have androgen deficiency

    Recruiting

    2 1 1 1
    Belgium

  • Study of ciltacabtagene autoleucel in patients with newly diagnosed multiple myeloma using a modified treatment preparation regimen

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ciltacabtagene Autoleucel
    Spain

  • Study of budesonide, glycopyrronium and formoterol inhaler to evaluate heart and lung function in patients with chronic obstructive pulmonary disease and hyperinflation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    • Budesonide
    Germany

  • Study comparing Sucrosomial Iron and Ferric Maltol treatment for women with iron deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency
    Spain

  • Study of glucagon effects on physical capacity in patients with heart failure with preserved ejection fraction (HFpEF) with or without liver steatosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Glucagon
    • Human Plasma Protein
    Germany

  • Study of intra-arterial angiotensin II during radioembolization to improve treatment effectiveness in patients with primary or secondary liver cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • ANGIOTENSIN II
    The Netherlands
Previous Page
1 … 124 125 126 127 128 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!